Continuum Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Continuum Advisory's LLY Position: Q2 2026 in Review
Continuum Advisory increased its Eli Lilly (LLY) stake by 94% in Q2 2026, buying an estimated $2.35M and bringing the position to 4,744 shares worth $5.69M. The position accounts for 0.46% of the portfolio, ranked #47.
Continuum Advisory first reported a position in LLY in Q2 2021 and has held it in 21 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Continuum Advisory held 4,744 shares of Eli Lilly worth $5.69M as of Q2 2026.
- Continuum Advisory bought 2,296 Eli Lilly shares in Q2 2026, an estimated $2.35M.
- Eli Lilly made up 0.46% of Continuum Advisory's portfolio in Q2 2026, its #47 holding.
- Continuum Advisory first reported a position in Eli Lilly in Q2 2021 and has held it in 21 quarters since.
- 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.